Search

Your search keyword '"Sheikh, Mujeeb"' showing total 287 results
Start Over Author "Sheikh, Mujeeb"
287 results on '"Sheikh, Mujeeb"'

1. Left atrial appendage closure device outcomes among cirrhosis patients with atrial fibrillation: a United States National Cohort Study

Author

Mir, Tanveer, Rawasia, Wasiq F, Uddin, Mohammed, Sheikh, Mujeeb, Munir, Muhammad Bilal, and Balla, Sudarshan

Subjects
Cardiovascular, Chronic Liver Disease and Cirrhosis, Digestive Diseases, Brain Disorders, Heart Disease, Liver Disease, Stroke, Patient Safety, Clinical Research, Humans, Female, United States, Atrial Fibrillation, Cohort Studies, Brain Ischemia, Retrospective Studies, Atrial Appendage, Gastrointestinal Hemorrhage, Treatment Outcome, Cirrhosis, Atrial fibrillation, Clinical outcomes, Coagulopathy, readmissions, LAAO, Clinical Sciences, Cardiovascular System & Hematology
Abstract

AimsLiterature regarding outcomes associated with atrial fibrillation among cirrhosis patients who had left atrial appendage occlusion (LAAO) device procedure is limited. We aim to evaluate the in-hospital clinical outcomes and 30-day readmissions among LAAO with and without cirrhosis.Methods and resultsWe performed a retrospective study of all hospitalizations associated with the LAAO procedure, using the Nationwide Readmissions Database for the years 2016-19. Primary outcomes were in-hospital clinical outcomes and 30-day readmissions. A total of 54 897 index hospitalizations for LAAO (female 41.8%) were reported. Of these, 905(1.65%) had cirrhosis. Gastrointestinal (GI) bleeding was reported in 44 (4.9%) vs. 1606 (2.97%) and coagulopathy in 21 (2.3%) vs. 521 (0.96%) in cirrhosis and without-cirrhosis groups, respectively. A total of 872 (1.59%) patients needed blood transfusion, 24 (2.7%) vs. 848(1.57%) in cirrhosis vs. without-cirrhosis groups (P = 0.047). Fresh frozen plasma (FFP) transfusion was reported among 888 (1.62%), with cirrhosis 26 (3%) vs. without cirrhosis 862 (1.6%) (P = 0.05). On adjusted multivariate logistic regression analysis, acute kidney injury, coagulopathy, FFP transfusion, and blood transfusion were strongly associated with cirrhosis, and GI bleeding, ischaemic stroke, and intracranial haemorrhage were not associated with cirrhosis. Readmissions in 30 days were 5028 (9.18%), 167 (18.5%) in the cirrhosis group and 4861 (9%) without-cirrhosis group (P = 0.01). On multivariate Cox regression, CHA2DS2-Vasc score of six was significantly associated with 30-day readmission compared with other scores [hazard ratio 2.24; 95% confidence interval (1.58-3.16); P < 0.001].ConclusionLeft atrial appendage occlusion procedure in patients with cirrhosis had relatively similar GI bleeding and stroke rates, however, had higher rates of 30-day readmission. A higher CHA2DS2-Vasc score was more likely to be associated with 30-day readmissions and hence would help in discharge planning. The long-term safety and efficacy of LAAO in the cirrhosis population need to be demonstrated.

Published
2023

3. Rationale and design for the myocardial ischemia and transfusion (MINT) randomized clinical trial

Author

Carson, Jeffrey L., Ghafghazi, Shahab, Cooper, Howard A., Wood, Frances, Menegus, Mark, Uretsky, Barry, Vallurupalli, Srikanth, Maniatis, Gregory, Gruberg, Luis, Roswell, Robert, Rossi, Joseph, Abtahian, Farhad, Tessalee, Meechai, Barsness, Gregory, Abbott, J. Dawn, Aronow, Herbert, Ramanathan, Kodangudi, Schmidhofer, Mark, Keating, Friederike, Carson, Michael, Kontos, Michael, Qureshi, Mansoor, Clegg, Stacey, Laskey, Warren, Polonsky, Tamar, Gupta, Rajesh, Sheikh, Mujeeb Abdul, Uhl, Lynne, Mullen, Paul, Bracey, Arthur, Matthai, William, Stowell, Christopher, Dudzinski, David, Marhefka, Gregary, Weinstock, Perry, Lawson, William, Keller, Norma, Yuriditsky, Eugene, Thomas, Michael, Jacobs, Alice, Hochberg, Claudia, Siddiqi, Omar, Schulman-Marcus, Joshua, Torosoff, Mikhail, Gitter, Michael, Dai, Xuming, Traverse, Jay, McCamant, Eric, Scott, Jason, Swaminathan, Rajesh, Rao, Sunil, Goldsweig, Andrew M., DeFilippis, Andrew P., Salisbury, Adam, Landers, David, Raveendran, Ganesh, Ebrahimi, Ramin, Bach, Richard, Delehanty, Joseph, Shah, Raj C., Brener, Sorin, Doroshow, Jonathan, Caixeta, Adriano, Precoma, Dalton, Dall'Orto, Frederico Toledo Campo, De Andrade, Pedro Beraldo, Dracoulakis, Marianna, Maia, Lília Nigro, Ritt, Luiz Eduardo Fontelles, Quadros, Alexandre, Filho, Dário Celestino Sobral, De Martino, Fernando, Huynh, Thao, Schnell, Greg, Senaratne, Manohara, Tandon, Vikas, Neary, John, Laflamme, David, Dery, Jean-Pierre, Bainey, Kevin, Haichin, Richard, Dehghani, Payam, Quraishi, Ata Ur Rehman, Potter, Brian J., Carrier, François Martin, Goldfarb, Michael, Fordyce, Christopher, Sia, Ying Tung, Daneault, Benoit, Madan, Mina, McPherson, Terry, Ducas, John, Minhas, Kunal, Brass, Neil, Bagai, Akshay, Robinson, Simon, Džavík, Vladimír, Khan, Razi, Michaud, Nicolas, Steg, Gabriel, Ducrocq, Gregory, Puymirat, Etienne, Lemesle, Gilles, Ferrari, Emile, Lattuca, Benoit, Silvain, Johanne, Vanzetto, Gérald, Cetran, Laura, Lhermusier, Thibault, Cottin, Yves, Rosamel, Yann, Angoulvant, Denis, Dillinger, Jean Guillaume, Thuaire, Christophe, Popovic, Batric, Durand, Eric, Bouleti, Claire, Roubille, François, Delorme, Laurent, Crozier, Ian, Benatar, Jocelyne, Nandra, Samraj, Ternouth, Ian, Fisher, Nick, Brieger, David, Hillis, Graham, Brooks, Maria Mori, Chaitman, Bernard R., Alexander, John H., Goodman, Shaun G., Bertolet, Marnie, Rao, Sunil V., Triulzi, Darrell J., Fergusson, Dean A., Kostis, William J., Noveck, Helaine, Simon, Tabassome, Steg, Philippe Gabriel, Lopes, Renato D., White, Harvey, Alsweiler, Caroline, Morton, Erin, and Hébert, Paul C.

Published
2023
Full Text
View/download PDF

19. Endovascular Transcatheter Aortic Valve Replacement Outcomes in Hypertrophic Cardiomyopathy: Insights from the National Inpatient Sample (2014–2018).

Author

Vyas, Rohit, Nazir, Salik, Ahuja, Keerat Rai, Minhas, Abdul Mannan Khan, Elzanaty, Ahmed, Mir, Tanveer, and Sheikh, Mujeeb

Subjects
HEART valve prosthesis implantation, HYPERTROPHIC cardiomyopathy, ARTERIAL grafts, ARTIFICIAL implants, CORONARY artery bypass, PERIPHERAL vascular diseases, PERCUTANEOUS coronary intervention
Abstract

Background: Outcomes of patients with hypertrophic cardiomyopathy (HCM) following transcatheter aortic valve replacement (TAVR) remain largely unknown. Objectives: This study sought to assess the clinical characteristics and outcomes of HCM patients following TAVR. Methods: We queried the National Inpatient Sample from 2014 to 2018 for TAVR hospitalizations with and without HCM, creating a propensity-matched cohort to compare outcomes. Results: 207,880 patients that underwent TAVR during the study period, 810 (0.38%) had coexisting HCM. In the unmatched population, TAVR patients with HCM compared to those without HCM, were more likely to be female, had a higher prevalence of heart failure, obesity, cancer, and history of pacemaker/implantable cardioverter defibrillation, and were more likely to have nonelective and weekend admissions (p for all <0.05). TAVR patients without HCM had higher prevalence of coronary artery disease, prior percutaneous coronary intervention, prior coronary artery bypass grafting, and peripheral arterial disease compared to their counterparts (p for all <0.05). In the propensity-matched cohort, TAVR patients with HCM had significantly higher incidence of in-hospital mortality, acute kidney injury/hemodialysis, bleeding complications, vascular complications, permanent pacemaker requirement, aortic dissection, cardiogenic shock, and mechanical ventilation requirement. Conclusion: Endovascular TAVR in HCM patients is associated with an increased incidence of in-hospital mortality and procedural complications. [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

41. Trends and complications associated with acute new-onset heart failure: a National Readmissions Database-based cohort study

Author

Sheikh Mujeeb, Mohammed Uddin, Ayman O. Soubani, Ghulam Saydain, Luis Afonso, Tanveer Mir, Waqas Qureshi, and Layla Shanah

Subjects
Adult, Male, Population, computer.software_genre, Patient Readmission, Ventricular Function, Left, law.invention, Coronary artery disease, Cohort Studies, law, medicine, Humans, education, Aged, Aged, 80 and over, Heart Failure, education.field_of_study, Ejection fraction, Database, business.industry, Mortality rate, Incidence (epidemiology), Stroke Volume, Middle Aged, medicine.disease, Prognosis, Intensive care unit, Hospitalization, Heart failure, Female, Cardiology and Cardiovascular Medicine, business, computer, Cohort study
Abstract

Literature regarding recent trends and outcomes of acute new-onset heart failure (AHF) with preserved ejection fraction (AHFpEF) and reduced ejection fraction (AHFrEF) is limited. The objective of this study is to study the outcomes of AHFpEF and AHFrEF in the USA. Data from the National Readmissions Database (NRD) sample that constitutes 49.1% of the stratified sample of all hospitals in the USA, representing more than 95% of the national population, were analyzed for hospitalization visits for acute heart failure. ICD-9 and ICD-10 codes were used to identify AHF. A total of 2,559,102 adult index AHF patients (mean age 70.79 ± 14.58 years, 49.4% females), 1,028,970 (40.2%) AHFpEF and 1,330,999 (52%) AHFrEF, were recorded in the National Readmissions Database for the years 2016–2018. A total of 152,465 (5.96%) acute heart failure, 47,271 (4.6%) AHFpEF and 91,973 (6.91%) AHFrEF, died during hospitalization, and 45,810 (1.9%) were readmitted in 30 days among alive discharges. Higher complication rates which included ventricular arrhythmias, acute coronary, and cerebrovascular events were observed among AHFrEF than AHFpEF. Higher proportion of patients with AHFrEF needed intensive care unit and ventilatory support during the hospitalization. The trend of incidence of AHFrEF, mortality among AHFrEF, and overall mortality worsened while AHFpEF improved over the study years 2012–2018 (p-trend

Published
2021

45. ST-Elevation Myocardial Infarction Among Septic Shock and Coronary Interventions: A National Emergency Database Study.

Author

Mir, Tanveer, Uddin, Mohammed, Qureshi, Waqas T., Abohashem, Shady, Alqalyoobi, Shehabaldin, Sheikh, Mujeeb, Soubani, Ayman, Saydain, Ghulam, and Albertson, Timothy E.

Subjects
MYOCARDIAL infarction, SEPTIC shock, CORONARY angiography, PERCUTANEOUS coronary intervention, MORTALITY
Abstract

Objective: To study coronary interventions and mortality among patients with ST-elevated myocardial infarction (STEMI) who were admitted with septic shock. Methods: Data from the national emergency department sample (NEDS) that constitutes 20% sample of hospital-owned emergency departments in the United States was analyzed for the septic shock related visits from 2016 to 2018. Septic shock was defined by the ICD codes. Results: Out of 1 375 507 adult septic shock patients, 521 300 had a primary diagnosis of septic shock (mean age 67.41 ±15.67 years, 51.1% females) in the national emergency database for the years 2016 to 2018. Of these patients, 2768 (0.53%) had STEMI recorded during the hospitalization. Mortality rates for STEMI patients were higher than patients without STEMI (52.3% vs 23.5%). Mortality rates improved with PCI among STEMI patients (43.8% vs 56.2%). Coronary angiography was performed among 16% of patients of which percutaneous coronary intervention (PCI) rates were 7.7% among patients with STEMI septic shock. PCI numerically improved mortality, however, had no significant difference than patients without PCI on multivariate logistic regression and univariate logistic regression post coarsened exact matching of baseline characteristics among STEMI patients. Among the predictors, STEMI was a significant predictor of mortality in septic shock patients (OR 2.87, 95% CI 2.37-3.49; P<.001). Age, peripheral vascular disease, were predominant predictors of mortality in STEMI with septic shock subgroup (P <.001). Pneumonia was the predominant underlying infection among STEMI (36.4%) and without STEMI group (29.5%). Conclusion: STEMI complicating septic shock worsens mortality. PCI and coronary angiography numerically improved mortality, however, had no significant difference from patients without PCI. More research will be needed to improve mortality in such a critically ill subgroup of patients. [ABSTRACT FROM AUTHOR]

Published
2022
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results